Achieve Life Sciences
ACHV
26 hedge funds and large institutions have $1.85M invested in Achieve Life Sciences in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
10% less funds holding
Funds holding: 29 → 26 (-3)
13% less capital invested
Capital invested by funds: $2.12M → $1.85M (-$274K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$528K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$41.3K |
| 3 |
Bank of New York Mellon
New York
|
+$10.9K |
| 4 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
+$10.9K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$7.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$54.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$42K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$9K |
| 4 |
Renaissance Technologies
New York
|
-$8.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.86K |
ACHV Hedge Fund Activity: Q1 2017 in Review
26 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q1 2017, worth a combined $1.85M — down 13% from $2.12M a quarter earlier.
Fund positioning in ACHV was balanced in Q1 2017: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $528K. The largest seller was Panagora Asset Management, cutting an estimated $54.6K.
- 26 institutional investors held Achieve Life Sciences (ACHV) as of Q1 2017, down from 29 in Q4 2016.
- Funds reported $1.85M of Achieve Life Sciences stock for Q1 2017, down 13% quarter-over-quarter.
- 3 funds opened new Achieve Life Sciences positions in Q1 2017 and 3 closed out, a net change of 0 holders.
- The largest Achieve Life Sciences buyer in Q1 2017 was BlackRock, an estimated $528K added.
- The largest Achieve Life Sciences seller in Q1 2017 was Panagora Asset Management, an estimated $54.6K sold.
Based on aggregated 13F filings for Q1 2017.